Videos

If you get a glioblastoma, you usually only have about 15 months to live.This malignant tumour spreads rapidly through the brain and unfortunately cannot be cured. Yanti De Visser is working on a personalised treatment to already slow down the brain tumour - with success. "The first results show that our approach has the potential to extend patients' lives by years, rather than months," she says.

Every 3 minutes, a woman dies of ovarian cancer somewhere in the world. "Ovarian cancer is very sneaky. Most of the patients respond positively to the therapies initially provided to them, but eventually, the cancer comes back and is much more aggressive. As a result one in two ovarian cancer patients die within 5 years after diagnosis." But what if we were able to treat ovarian cancer with a new therapy using our cells?

Why do people get cancer, arthritis, or Alzheimer's? Essentially because a protein key in our body does not fit in its respective lock. This is why Alvaro Martin is looking at removing defective keys and designing new protein keys. Keys that fit and can open the necessary locks, so that for example, our immune cells target and kill cancerous cells. "Protein design can be the key to unlocking a future without diseases."

Fighting cancer with wisdom teeth - it almost sounds like the tooth fairy's fairy tale. And yet it is a fairy tale that could well come true. Jolien Van den Bosch (UHasselt) wants to use stem cells from wisdom teeth to develop a new therapy against cancer. One could even say she's fighting ... tooth and nail to make this happen.

A stupid accident, cancer, or a hernia - it can all cause a spinal cord injury in which certain parts of your body are then paralysed. But there is also a hidden effect - an effect in the blood, explains Naomi Veeningen (UHasselt) 🩸

Thanks to advanced proton therapy, doctors can precisely start irradiating brain tumours. Unfortunately, they do not yet dare to use this technique on tumours in the belly. Why? Because it's a bit like playing darts with a blindfold, while you have to hit a moving target, as Sophie Heymans explains in this video. She tells you about the technique she is working on to help doctors face this challenge.

Up to 25% of the cells present in lung cancer tumours are currently ignored. As such, we don't know what the role of these so-called B cells is. "It is crucial to figure that out because we cannot efficiently fight something we do not fully understand," says Pauline Bardet (VUB - VIB - FWO).

In her PhD, she wants to get to the bottom of those B cells and thus find out whether those cells are "good guys" or "bad guys".

Anyone who has ever looked for Waldo knows how hard he is to find. In her research on lung cancer, Rebekka Van Hoof (Uhasselt - KU Leuven - VITO) faces a similar task: she is searching within more than 100,000 so-called extracellular vesicles for 2 types -say 'Waldos'- that can help detect the disease early. But she is determined to narrow her search field. How? Watch her explain it in this video. 

Do you remember Pac-Man, from that old skool computer game? Well, did you know that there are Pac-Mans in every single cell of our body? They're called enzymes. Some of these enzymes work too fast or too slow, and this can cause severe diseases. Michaela Prothiwa (KU Leuven) explains how she wants to track down these malfunctioning enzymes using a clever piece of chemistry.

What if you only had 15 months to live? Hard to imagine, right? Yet every day, around 1,000 people worldwide hear this news. The verdict: glioblastoma, a malignant brain tumor. Yet a small group of patients manages to survive for more than 10 years with such a brain tumor. Brecht Decraene wants to finds out why.

Cancer patients often become heart patients. This is because chemotherapy affects not only cancer cells but also healthy cells, such as the heart muscle cells. In order to prevent heart damage after chemotherapy, we first need to know what factors increase the risk of heart damage. And that is what Sibren Haesen (Uhasselt) has made his mission. With his Ph.D., he wants to help ensure that today's cancer patients do not become tomorrow's heart patients.

"Each person is unique. So why do we still treat every woman with ovarian cancer the same way?" Liselore Loverix (KU Leuven - FWO) examines patient by patient and looks for errors in the DNA of their tumour cells. In this way, before treatment starts, she identifies which patient would benefit from a new, targeted therapy based on cancer drugs.